|
- 2018
颌骨成釉细胞癌10例临床分析
|
Abstract:
摘要 目的: 报道10例颌骨成釉细胞癌的临床特点、治疗和预后。方法: 回顾性分析2012~2016年间就诊的10例颌骨成釉细胞癌患者的临床资料。结果: 本组病例中,男性7例,女性3例,男女比例为2.3∶1,发病年龄17~85岁,中位年龄52岁,原发型2例,继发型8例,2例发生于上颌骨,8例发生于下颌骨,其中3例见于下颌骨左侧。3例患者曾有手术治疗史,6例病变累及下颌骨磨牙、升支区。患者就诊的主要原因为颌面部的肿胀、疼痛,所有患者均接受手术治疗,同期行颈淋巴清扫术者4例,术后未发现颈部淋巴结有转移癌形成;同期行植骨术者4例,其中腓骨肌皮瓣1例,髂骨肌瓣3例。随访1.5~4年,2例患者失访,4例患者出现复发,其中2例患者曾有保守治疗手术史。结论: 成釉细胞癌为罕见的颌骨恶性肿瘤,临床表现常不典型,提高对该病认识,有利于为患者选择适宜的治疗方案,降低复发率
[1] | Yoon HJ, Hong SP, Lee JI, et al. Ameloblastic carcinoma: an analysis of 6 cases with review of the literature [J] . Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2009,108(6)∶904-913 |
[2] | Hall JM, Weathers DR, Unni KK. Ameloblastic carcinoma: an analysis of 14 cases [J] . Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2007, 103(6)∶799-807 |
[3] | [M] . Germany,Springer,2014.1-3 |
[4] | Akrish S, Buchner A, Shoshani Y, et al. Ameloblastic carcinoma: report of a new case, literature review, and comparison to ameloblastoma [J] . J Oral Maxillofac Surg, 2007, 65(4)∶777-783 |
[5] | Klapsinou E, Stavros A, Smaragda A, et al. Fine-needle aspiration cytology of ameloblastoma and malignant ameloblastoma: A study of 12 cases [J] . Diagn Cytopathol, 2013, 41(3)∶206-211 |
[6] | Trivedi N. Atlas of head and neck cancer surgery: the compartment surgery for resection in 3-D |
[7] | Martínez-Martínez M, Mosqueda-Taylor A, Carlos-Bregni R, et al. Comparative histological and immunohistochemical study of ameloblastomas and ameloblastic carcinomas [J] . Med Oral Patol Oral Cir Bucal, 2017, 22(3)∶e324-e332 |
[8] | García-Mu oz A, Rodríguez MA, Licéaga-Escalera C, et al. Expression of the transcription factor PITX2 in ameloblastic carcinoma [J] . Arch Oral Biol, 2015, 60(6)∶799-803 |
[9] | Jensen AD, Ecker S, Ellerbrock M, et al. Carbon ion therapy for ameloblastic carcinoma [J] . Radiat Oncol, 2011, 6∶13 |
[10] | Soluk-Tekk in M, Wright JM. The World Health Organization classification of odontogenic lesions: a summary of the changes of the 2017 (4th) edition [J] . Turk Patoloji Derg, 2018, 34(1) |
[11] | Nardis AC, Gon alves S, Nagata G, et al. Mandible ameloblastic carcinoma of difficult diagnosis: a case report [J] . Oral Surgery, 2016, 9(2)∶113-118 |
[12] | Saluja TS, Hosalkar R. Reconnoitre ameloblastic carcinoma: A prognostic update [J] . Oral Oncology, 2018, 77∶118-124 |
[13] | 张德明,王江涛.锥形束CT在下颌骨肿瘤和肿瘤样病变检查中的应用[J] .口腔医学研究,2015,31(3)∶290-293 |
[14] | Lei Y, Jaradat JM, Owosho A, et al. Evaluation of SOX2 as a potential marker for ameloblastic carcinoma [J] . Oral Surg Oral Med Oral Pathol Oral Radiol, 2014, 117(5)∶608-616.e1 |
[15] | Giridhar P, Mallick S, Upadhyay AD, et al. Pattern of care and impact of prognostic factors in the outcome of ameloblastic carcinoma: a systematic review and individual patient data analysis of 199 cases [J] . Eur Arch Otorhinolaryngol, 2017, 274(10)∶3803-3810 |
[16] | Liu JY, Man QW, Ma YQ, et al. I 125 brachytherapy guided by individual three-dimensional printed plates for recurrent ameloblastoma of the skull base [J] . Br J Oral Maxillofac Surg, 2017, 55(7)∶e38-e40 |
[17] | Diniz MG, Gomes CC, Guimaraes BV, et al. Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours [J] . Tumour Biol, 2015, 36(7)∶5649-5653 |